Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-80.87M
↓ 15% below average
Average (6y)
$-70.17M
Historical baseline
Range
High:$-8.56M
Low:$-116.55M
CAGR
+45.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-80.87M | -2.4% |
| 2023 | $-79.02M | +1.6% |
| 2022 | $-80.33M | +31.1% |
| 2021 | $-116.55M | -52.7% |
| 2020 | $-76.33M | -54.0% |
| 2019 | $-49.55M | -478.6% |
| 2018 | $-8.56M | - |